An Overview of Common Designer Drugs

November 27, 2017

Marisa Rivera, MD

Target Audience

Internal Medicine 

Learning Objectives

1) Discuss the  current trends in synthetic drug use and the impact on ED visit and morbidity and mortality
2) Screen for the recreational drug use when there is a high clinical suspicion
3) Utilize treatment options for overdose of popular drugs and offer appropriate support services

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Course opens: 
Course expires: 
Event starts: 
11/27/2017 - 12:30pm PST
Event ends: 
11/27/2017 - 1:30pm PST

The presenter & planning committee members for this activity have disclosed that they have no relevant relationships with commercial or industry organizations. The CME Department has reviewed their disclosure information for the planner(s) and/or committee/faculty for this program and they do not have relationships that present a relevant conflict of interest. Kaiser Permanente does not endorse any brand name products.

Kaiser Santa Clara is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The Kaiser Santa Clara designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Please login or register to take this course.